Director Dealing (3102R)
November 02 2011 - 2:01AM
UK Regulatory
TIDMXCT
RNS Number : 3102R
XCounter AB
02 November 2011
PRESS RELEASE
Stockholm, 2 November 2011
Director Dealing
XCounter AB (AIM: XCT) ("XCounter" or the "Company"), a
technology leader in the development and supply of specialty X-ray
detectors, announces that the Company has been notified that XR
Invest AS, a subsidiary company of Visuray plc, has acquired
200,000 ordinary shares at a price of 3.86 pence per share on
Monday 31 October 2011.
As a result of the purchase XR Invest AS subsequently holds
40,585,920 ordinary shares, being 20.76% of the companies issued
share capital. XR Invest AS also has options to acquire a further
10,650,822 shares in XCounter.
Visuray plc subsequently holds, directly and indirectly, a total
of 78,487,733 ordinary shares, being 40.15% of the companies issued
share capital.
As a consequence Jean-Philippe Stork Flament, Non Executice
Chairman of XCounter, who is an Alternate Director of XR Invest AS
and Chairman of Visuray plc, now has an interest in 40.15% of the
issued share capital of the Company.
For further information, please contact:
XCounter AB Tel: +46 (0) 8 622 23 00
Mikael Strindlund, CEO
Singer Capital Markets Limited Tel: +44 (0) 20 3205 7500
Shaun Dobson / Claes Spang
Capital MS&L Tel: +44 (0) 207 307 5330
Anna Davies
About XCounter AB
XCounter AB is a leader in the development and supply of direct
conversion, photon counting and tomosynthesis based 3D X-ray
imaging technologiesfor medical, dental and industrial X-ray
imaging.
Headquartered in Stockholm, XCounter employs 28 people in its
facilities in Sweden and Finland. For more detailed information,
please visit:www.xcounter.se
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZMMGMNMFGMZM
Xcounter (LSE:XCT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xcounter (LSE:XCT)
Historical Stock Chart
From Sep 2023 to Sep 2024